![All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex | British Journal of Cancer All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-02074-0/MediaObjects/41416_2022_2074_Fig1_HTML.png)
All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex | British Journal of Cancer
![Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. | Semantic Scholar Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c9d3cf2b0dc02ef9af3d7210277d5a6aca04fe35/4-Table3-1.png)
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. | Semantic Scholar
![PDF) Differentiation Syndrome in Promyelocytic Leukemia: Clinical Presentation, Pathogenesis and Treatment PDF) Differentiation Syndrome in Promyelocytic Leukemia: Clinical Presentation, Pathogenesis and Treatment](https://i1.rgstatic.net/publication/51824437_Differentiation_Syndrome_in_Promyelocytic_Leukemia_Clinical_Presentation_Pathogenesis_and_Treatment/links/00b495189535b5796c000000/largepreview.png)
PDF) Differentiation Syndrome in Promyelocytic Leukemia: Clinical Presentation, Pathogenesis and Treatment
Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin | Haematologica
![Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. | Semantic Scholar Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c9d3cf2b0dc02ef9af3d7210277d5a6aca04fe35/3-Figure1-1.png)
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. | Semantic Scholar
![Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration - ScienceDirect Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213048919300524-gr1.jpg)
Rate of differentiation syndrome in patients based on timing of initial all-trans retinoic acid administration - ScienceDirect
![PDF) Differentiation Syndrome In Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid and Anthracycline Chemotherapy: Characteristics, Outcome, … | ANGEL MANUEL RUBIO LEON - Academia.edu PDF) Differentiation Syndrome In Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid and Anthracycline Chemotherapy: Characteristics, Outcome, … | ANGEL MANUEL RUBIO LEON - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/81682790/mini_magick20220303-16974-bmk7t.png?1646362357)